Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
Abstract: The paper proposes a detailed analysis of electric vehicle (EV) battery modelling, state estimation, and charging infrastructure in an integrated MATLAB Simscape framework. As EV penetration ...
Abstract: This study aims to utilize Simscape/MATLAB tool potential to investigate the dynamic behavior of an air conditioning system and analyze the effects of many parameters on the performance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results